These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 880416)

  • 1. Development of parenteral and sterile ophthalmic suspensions--the R & D approach.
    Portnoff JB; Cohen EM; Henley MW
    Bull Parenter Drug Assoc; 1977; 31(3):136-43. PubMed ID: 880416
    [No Abstract]   [Full Text] [Related]  

  • 2. Sterile ophthalmic ointment and suspension manufacturing.
    Abshire R; Cash P
    J Parenter Sci Technol; 1986; 40(3):97-9. PubMed ID: 3746580
    [No Abstract]   [Full Text] [Related]  

  • 3. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Claims of IKS principles].
    Witschi T
    Pharm Acta Helv; 1973 Feb; 48(2):53-62. PubMed ID: 4706309
    [No Abstract]   [Full Text] [Related]  

  • 4. Current regulatory issues regarding sterile products.
    Avallone H
    J Parenter Sci Technol; 1990; 44(4):228-30. PubMed ID: 2213432
    [No Abstract]   [Full Text] [Related]  

  • 5. Procedures important in the manufacture of ophthalmic preparations.
    Rosenberg SJ
    Bull Parenter Drug Assoc; 1970; 24(2):94-7. PubMed ID: 5439918
    [No Abstract]   [Full Text] [Related]  

  • 6. Parenteral suspensions.
    Nash RA
    Bull Parenter Drug Assoc; 1972; 26(2):91-4. PubMed ID: 5012208
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comments and control studies on the size of drug particles contained in ophthalmic ointments].
    Doden W; Faulborn J
    Klin Monbl Augenheilkd; 1967; 150(5):727-32. PubMed ID: 5586134
    [No Abstract]   [Full Text] [Related]  

  • 8. Design and operation of a new sterile manufacturing facility.
    Fornabaio TA
    Bull Parenter Drug Assoc; 1970; 24(3):110-8. PubMed ID: 5422900
    [No Abstract]   [Full Text] [Related]  

  • 9. The manufacture of sterile topical products.
    Longworth AR
    Bull Parenter Drug Assoc; 1975; 29(5):238-49. PubMed ID: 1182334
    [No Abstract]   [Full Text] [Related]  

  • 10. Guidelines for the preparation of sterile ophthalmic products.
    Reynolds LA
    Am J Hosp Pharm; 1991 Nov; 48(11):2438-9. PubMed ID: 1746580
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of sterilizing-grade filters on the physico-chemical properties of onion-like vesicles.
    Richard A; Delvaux J; Bourel-Bonnet L
    Int J Pharm; 2006 Apr; 312(1-2):144-50. PubMed ID: 16480839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiological control in the manufacture of sterile pharmaceutical products.
    Bühlmann X
    Pharm Acta Helv; 1971 Jul; 46(7):385-409. PubMed ID: 4934853
    [No Abstract]   [Full Text] [Related]  

  • 13. BASICS OF STERILE COMPOUNDING: Sterilization Methods in Sterile Product Manufacturing.
    Akers MJ
    Int J Pharm Compd; 2015; 19(2):127-38. PubMed ID: 26685494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sterile ophthalmic ointments--pilot plant phase.
    O'Neill JL; Polli GP; Fong DT
    Bull Parenter Drug Assoc; 1973; 27(5):201-6. PubMed ID: 4746694
    [No Abstract]   [Full Text] [Related]  

  • 15. Design and construction of an Australian sterile products plant.
    Woods AD
    Bull Parenter Drug Assoc; 1975; 29(1):26-38. PubMed ID: 1125471
    [No Abstract]   [Full Text] [Related]  

  • 16. [PREPARATION OF INJECTABLE DRUG SUSPENSIONS. I. PREPARATION OF A 2.5 O AQUEOUS SUSPENSION OF DESOXYCORTICOSTERONE TRIMETHYLACETATE].
    VOLKOVINSKAIA LP; POZHARSKAIA AM
    Med Prom SSSR; 1963 Jul; 17():42-3. PubMed ID: 14069026
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship of quality control to good manufacturing procedures for lyophilized parenteral products.
    Wickes G
    Bull Parenter Drug Assoc; 1965; 19(5):135-41. PubMed ID: 5826304
    [No Abstract]   [Full Text] [Related]  

  • 18. THE FORMULATION AND MANUFACTURING OF STERILE PHARMACEUTICAL PRODUCTS.
    KIRSCH NC
    Pharm Weekbl; 1965 Mar; 100():413-28. PubMed ID: 14330876
    [No Abstract]   [Full Text] [Related]  

  • 19. Formulation design and development of parenteral suspensions.
    Akers MJ; Fites AL; Robison RL
    J Parenter Sci Technol; 1987; 41(3):88-96. PubMed ID: 3612415
    [No Abstract]   [Full Text] [Related]  

  • 20. Ophthalmic preservatives and vehicles.
    Mullen W; Shepherd W; Labovitz J
    Surv Ophthalmol; 1973; 17(6):469-83. PubMed ID: 4213278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.